Viewing Study NCT05743595


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2025-12-25 @ 12:26 PM
Study NCT ID: NCT05743595
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2023-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Sponsor: Washington University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module